Information Provided By:
Fly News Breaks for July 20, 2016
JNJ
Jul 20, 2016 | 08:14 EDT
Leerink analyst Danielle Antalffy believes Johnson & Johnson recent growth momentum is likely to continue, noting that the company delivered its fifth consecutive quarter of organic sales growth acceleration, now "solidly" in the mid-single-digits. Furthermore, the analyst believes the company will remain a "safe haven" in a volatile market. Antalffy reiterates an Outperform rating and $140 price target on the shares.